Opportunistic Infections
Antiretroviral Therapy Reduces Cytomegalovirus in HIV-1 Patients
Published in Virus Weekly, October 17th, 2000
"Visualization of antigen-specific T cells has become an important tool in studying immune responses," stated V. Grosse and colleagues. "The aim of this study was to analyze CMV-specific CD4+ T cells in healthy and HIV infected individuals."
The researchers examined peripheral blood mononuclear cells (PBMC) for antigen-induced intracellular cytokine responses. They detected significant numbers of CMV-specific CD4+ T cells in most CMV-immunoglobulin G (IgG+) HIV-1 infected individuals, but did not...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
Source: Virus Weekly (2000-10-17)
More Articles from Virus Weekly
- Disease Associations
Link Between Epstein-Barr Virus and Multiple Sclerosis Studied - Hantavirus Pulmonary Syndrome
Similarities Characterize Strains Detected in South American Virus Isolates - Dementia
Researchers to Determine if Anti-Inflammatories are Useful for AIDS Dementia, Alzheimer's - Hearing Loss
Acyclovir Combined with Steroids Restores Sudden Hearing Loss Due to Viral Infection - Influenza
Experts Decide Content of 2001 "Southern Hemisphere" Vaccine - Drug Development
Antiviral and Anti-Inflammatory Experimental Drug Licensed - More from this issue of Virus Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
